An official website of the United States government
Awarded Grants for CISNET I and CISNET II
This page lists all of CISNET's grantees and affiliates during the first two funding phases.
On this page:
CISNET Affiliate Program
CISNET encourages the participation of modelers who are not funded through the CISNET mechanism. Currently CISNET has eight affiliate members in cancer site groups: three in breast, three in colorectal, and two in lung. Investigators working on population modeling of cancer trends who wish to be associated with the CISNET group may apply for affiliate status. Affiliates attend meetings, share results, and participate in joint collaborations when applicable.
Breast Cancer Modeling Grants
| Principal Investigator and Institution |
Title |
CISNET I (R1 or R2*) |
CISNET II |
|---|---|---|---|
| Donald A. Berry, Ph.D. M. D. Anderson Cancer Center |
Cancer Intervention and Surveillance Modeling Network (CISNET) | Funded R1 | Affiliate |
| Dennis G. Fryback, Ph.D. University of Wisconsin - Madison |
Simulating Breast Cancer in Wisconsin | Funded R1 | - |
| J. Dik F. Habbema, Ph.D. Erasmus MC, University Medical Center Rotterdam |
Surveillance of Breast Cancer Trends by MISCAN | Funded R1 | - |
| Jeanne Mandelblatt, M.D., M.P.H. Georgetown University Medical Center1 |
CISNET: The "Spectrum" of Breast Cancer Disparities | Funded R1 | Funded |
| Sylvia K. Plevritis, Ph.D. Stanford University |
Breast Cancer Trend Analysis Using Stochastic Simulation | Funded R1 | Funded |
| Andrei Y. Yakovlev, Ph.D. University of Rochester |
Mechanistic Modeling of Breast Cancer Surveillance | Funded R1 | - |
| Sandra Lee, D.Sc. (current PI) Marvin Zelen, Ph.D. (previous PI) Dana-Farber Cancer Institute |
Breast Cancer: Role of Early Detection, Treatment and Prevention | Funded R1 | Funded |
| Leslie Gaudette, M.Sc. Health Canada |
- | Affiliate | |
| Oguzhan Alagoz, Ph.D. and Amy Trentham-Dietz, Ph.D. University of Wisconsin - Madison |
Using The UWBCS To Assess Racial Disparities In Breast Cancer Incidence & Survival | - | Affiliate |
| Natasha Stout, Ph.D. Harvard Medical School/Harvard Pilgrim Health Care |
- | Affiliate |
Colorectal Cancer Modeling Grants
| Principal Investigator and Institution |
Title (click for abstract) |
CISNET I (R1 or R2*) |
CISNET II |
|---|---|---|---|
| Karen M. Kuntz, D.Sc. University of Minnesota School of Public Health3 |
A Population-Based Policy Model for Colorectal Cancer | Funded R1 | Funded |
| Carolyn M. Rutter, Ph.D. Group Health Research Institute |
Colorectal Cancer Screening: Evaluating Trends and Outcomes | Funded R2 | Funded |
| Ann G. Zauber, Ph.D. Sloan Kettering Institute for Cancer Research1 |
Colorectal Cancer Surveillance with MISCAN Modeling | Funded R2 | Funded |
| Georg Luebeck, Ph.D. Fred Hutchinson Cancer Research Center |
Modeling Colon Cancer, Intervention and Prevention | - | Affiliate |
| Scott D. Ramsey, Ph.D. Fred Hutchinson Cancer Research Center1 |
A Genetic Screening Policy Model for Colorectal Cancer | - | Affiliate |
| David Vanness, Ph.D. University of Wisconsin Medical School |
Cost-Effectiveness Modeling of ACRIN 6664 (National Colongraphy Trial) | - | Affiliate |
Colorectal Cancer Coordinating Center Grant
| Principal Investigator and Institution |
Title (click for abstract) |
CISNET I (R1 or R2*) |
CISNET II |
|---|---|---|---|
| Ann G. Zauber, Ph.D. Sloan Kettering Institute for Cancer Research1 |
Coordinating Center for Colorectal Microsimulation | - | Funded |
Lung Cancer Modeling Grants
| Principal Investigator and Institution |
Title (click for abstract) |
CISNET I (R1 or R2*) |
CISNET II |
|---|---|---|---|
| Harry de Koning, M.D., Ph.D. (current PI) Erasmus MC, University Medical Center Rotterdam Rob Boer, Ph.D. (previous PI) RAND Corporation |
Cancer Intervention and Surveillance Modeling Network | Funded R2 | Funded |
| Theodore R. Holford, Ph.D. Yale University |
Modeling Interventions for Lung Cancer Mortality | Funded R2 | Funded |
| Marek Kimmel, Ph.D. Rice University2 |
Modeling Lung Cancer: Risks, Progression, and Screening | Funded R2 | Funded |
| David T. Levy, Ph.D. Pacific Institute for Research and Evaluation |
A Simulation of Tobacco Policy, Smoking and Lung Cancer | Funded R2 | Funded |
| Suresh H. Moolgavkar, M.D., Ph.D. Fred Hutchinson Cancer Research Center |
Lung Cancer in the US: Pathogenesis, Trends, Prevention | Funded R2 | Funded |
| G. Scott Gazelle, M.D., M.P.H., Ph.D. Massachusetts General Hospital |
A Lung Cancer Policy Model | - | Affiliate |
| Sylvia K. Plevritis, Ph.D. Stanford University |
Cost-Effectiveness Analysis of Lung Cancer Screening | - | Affiliate |
Prostate Cancer Modeling Grants
| Principal Investigator and Institution |
Title (click for abstract) |
CISNET I (R1 or R2*) |
CISNET II |
|---|---|---|---|
| Harry de Koning, M.D., Ph.D. Erasmus MC, University Medical Center Rotterdam |
A Trial-based MISCAN Model for Prostate Cancer | - | Funded |
| Ruth Etzioni, Ph.D. Fred Hutchinson Cancer Research Center |
PSA Screening and U.S. Prostate Cancer Trends | Funded R1 | Funded |
| Alexander Tsodikov, Ph.D. University of Michigan |
Survival Effects of Prostate Cancer Surveillance | Funded R2 | Funded |
* CISNET I was funded in two rounds: The first round (R1) began in 2000, followed by the second round (R2) in 2002.
1 Collaboration with Erasmus MC, University Medical Center Rotterdam (MISCAN model).
2 Collaboration with M. D. Anderson Cancer Center and Weil Cornell Medical Center.
3 Collaboration with Massachusetts General Hospital.
Location of the CISNET II Grantees and Affiliates
